Your browser doesn't support javascript.
loading
Treatment data from the Brazilian fibromyalgia registry (EpiFibro)
Assis, Marcos Renato de; Paiva, Eduardo dos Santos; Helfenstein Junior, Milton; Heymann, Roberto Ezequiel; Pollak, Daniel Feldman; Provenza, Jose Roberto; Ranzolin, Aline; Rezende, Marcelo Cruz; Ribeiro, Luiz Severiano; Souza, Eduardo José R; Martinez, José Eduardo.
  • Assis, Marcos Renato de; Faculdade de Medicina de Marília. Marília. BR
  • Paiva, Eduardo dos Santos; Sociedade Brasileira de Reumatologia. São Paulo. BR
  • Helfenstein Junior, Milton; Sociedade Brasileira de Reumatologia. São Paulo. BR
  • Heymann, Roberto Ezequiel; Sociedade Brasileira de Reumatologia. São Paulo. BR
  • Pollak, Daniel Feldman; Sociedade Brasileira de Reumatologia. São Paulo. BR
  • Provenza, Jose Roberto; Sociedade Brasileira de Reumatologia. São Paulo. BR
  • Ranzolin, Aline; Sociedade Brasileira de Reumatologia. São Paulo. BR
  • Rezende, Marcelo Cruz; Sociedade Brasileira de Reumatologia. São Paulo. BR
  • Ribeiro, Luiz Severiano; Sociedade Brasileira de Reumatologia. São Paulo. BR
  • Souza, Eduardo José R; Sociedade Brasileira de Reumatologia. São Paulo. BR
  • Martinez, José Eduardo; Sociedade Brasileira de Reumatologia. São Paulo. BR
Adv Rheumatol ; 60: 09, 2020. tab, graf
Article in English | LILACS | ID: biblio-1088656
ABSTRACT
Abstract

Background:

EpiFibro (Brazilian Epidemiological Study of Fibromyalgia) was created to study patients with fibromyalgia (FM). Patients were included since 2011 according to the classification criteria for FM of the American College of Rheumatology of 1990 (ACR1990).

Objective:

To analyze the therapeutic measures prescribed by Brazilian physicians. Materials and

methods:

Cross-sectional study of a multicenter cohort. The therapeutic measures were described using descriptive statistics.

Results:

We analyzed 456 patients who had complete data in the registry. The mean age was 54.0 ± 11.9 years; 448 were women (98.2%). Almost all patients (98.4%) used medications, 62.7% received health education, and less than half reported practicing physical exercise; these modalities were often used in combination. Most patients who practiced exercises practiced aerobic exercise only, and a significant portion of patients combined it with flexibility exercises. The most commonly used medication was amitriptyline, followed by cyclobenzaprine, and a minority used medication specifically approved for FM, such as duloxetine and pregabalin, either alone or in combination. Combinations of two or three medications were observed, with the combination of fluoxetine and amitriptyline being the most frequent (18.8%).

Conclusion:

In this evaluation of the care of patients with FM in Brazil, it was found that the majority of patients are treated with a combination of pharmacological measures. Non-pharmacological methods are underused, with aerobic exercise being the most commonly practiced exercise type. The most commonly prescribed single drug was amitriptyline, and the most commonly prescribed combination was fluoxetine and amitriptyline. Drugs specifically approved for FM are seldom prescribed.(AU)
Subject(s)


Full text: Available Index: LILACS (Americas) Main subject: Fibromyalgia Type of study: Controlled clinical trial / Etiology study / Incidence study / Observational study / Prevalence study / Prognostic study / Risk factors Limits: Humans Country/Region as subject: South America / Brazil Language: English Journal: Adv Rheumatol Journal subject: Artrite / Reumatologia Year: 2020 Type: Article Affiliation country: Brazil Institution/Affiliation country: Faculdade de Medicina de Marília/BR / Sociedade Brasileira de Reumatologia/BR

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Main subject: Fibromyalgia Type of study: Controlled clinical trial / Etiology study / Incidence study / Observational study / Prevalence study / Prognostic study / Risk factors Limits: Humans Country/Region as subject: South America / Brazil Language: English Journal: Adv Rheumatol Journal subject: Artrite / Reumatologia Year: 2020 Type: Article Affiliation country: Brazil Institution/Affiliation country: Faculdade de Medicina de Marília/BR / Sociedade Brasileira de Reumatologia/BR